Socías ME, Nolan S Can extended-release injectable medications help curb United States and Canada's opioid overdose epidemic? J Addict Med, 2021. PubMed
Bach P, Ti L Hepatitis C and stimulant use disorder: challenges and opportunities Clin Infect Dis, 2020. PubMed
Long V, Arredondo J, Ti L, Grant C, DeBeck K, Milloy MJ, Lysyshyn M, Wood E, Kerr T, Hayashi K Factors associated with drug checking service utilization among people who use drugs in a Canadian setting Harm Reduct J, 2020. PubMed
Ryan A, Sereda A, Fairbairn N Measures to support a safer drug supply CMAJ, 2020. PubMed
Beaulieu T, Barbic S, Milloy MJ, Puri N, Hayashi K, Ti L PMH24 Factors associated with receiving integrated care among people with concurrent opioid use disorder and mental illness in a Canadian setting Value Health, 2020. Link
Kennedy MC, Milloy MJ, Hayashi K, Holliday E, Wood E, Kerr T Assisted injection within supervised injection services: uptake and client characteristics among people who require help injecting in a Canadian setting Int J Drug Policy, 2020. PubMed
Lake S, St. Pierre M The relationship between cannabis use and patient outcomes in medication-based treatment of opioid use disorder: a systematic review Clin Psychol Rev, 2020. PubMed
MacKinnon L, Socías ME, Bardwell G COVID-19 and overdose prevention: challenges and opportunities for clinical practice in housing settings J Subst Abuse Treat, 2020. PubMed
Bach P, Garrod E, Robinson K, Fairbairn N An acute care contingency management program for the treatment of stimulant use disorder: a case report J Addict Med, 2020. PubMed
Collins AB, McNeil R, Czechaczek S, Boyd J "That’s what I’m supposed to do at work": gendered labor, self-care, and overdose risk among women who use drugs in Vancouver, Canada Crit Public Health, 2020. Link
